The two strategies currently explored to induce NIS expression in cancer cells include the transfer of NIS gene using vectors (mainly viruses) and constructs able to ensure the selective expression in tumor cells, or, alternatively, the stimulation of the expression of a functional endogenous NIS. This evidence concerns the gene SLC5A5 and cancer.